Global Activated Prothrombin Complex Concentrate (aPCC) Market Growth 2026-2032
The global Activated Prothrombin Complex Concentrate (aPCC) market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Activated Prothrombin Complex Concentrate (aPCC) is a blood coagulation factor complex commonly used to treat bleeding disorders, especially bleeding problems caused by coagulation factor deficiency. This complex contains a variety of coagulation factors, such as prothrombin, thrombin, fibrinogen, etc., which can help restore normal coagulation function by supplementing missing coagulation factors.
United States market for Activated Prothrombin Complex Concentrate (aPCC) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Activated Prothrombin Complex Concentrate (aPCC) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Activated Prothrombin Complex Concentrate (aPCC) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Activated Prothrombin Complex Concentrate (aPCC) players cover Takeda, Octapharma AG, CSL Behring GmbH, Grifols, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Activated Prothrombin Complex Concentrate (aPCC) Industry Forecast? looks at past sales and reviews total world Activated Prothrombin Complex Concentrate (aPCC) sales in 2025, providing a comprehensive analysis by region and market sector of projected Activated Prothrombin Complex Concentrate (aPCC) sales for 2026 through 2032. With Activated Prothrombin Complex Concentrate (aPCC) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Activated Prothrombin Complex Concentrate (aPCC) industry.
This Insight Report provides a comprehensive analysis of the global Activated Prothrombin Complex Concentrate (aPCC) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Activated Prothrombin Complex Concentrate (aPCC) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Activated Prothrombin Complex Concentrate (aPCC) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Activated Prothrombin Complex Concentrate (aPCC) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Activated Prothrombin Complex Concentrate (aPCC).
This report presents a comprehensive overview, market shares, and growth opportunities of Activated Prothrombin Complex Concentrate (aPCC) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Activated Prothrombin Complex Concentrate (aPCC) is a blood coagulation factor complex commonly used to treat bleeding disorders, especially bleeding problems caused by coagulation factor deficiency. This complex contains a variety of coagulation factors, such as prothrombin, thrombin, fibrinogen, etc., which can help restore normal coagulation function by supplementing missing coagulation factors.
United States market for Activated Prothrombin Complex Concentrate (aPCC) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Activated Prothrombin Complex Concentrate (aPCC) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Activated Prothrombin Complex Concentrate (aPCC) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Activated Prothrombin Complex Concentrate (aPCC) players cover Takeda, Octapharma AG, CSL Behring GmbH, Grifols, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Activated Prothrombin Complex Concentrate (aPCC) Industry Forecast? looks at past sales and reviews total world Activated Prothrombin Complex Concentrate (aPCC) sales in 2025, providing a comprehensive analysis by region and market sector of projected Activated Prothrombin Complex Concentrate (aPCC) sales for 2026 through 2032. With Activated Prothrombin Complex Concentrate (aPCC) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Activated Prothrombin Complex Concentrate (aPCC) industry.
This Insight Report provides a comprehensive analysis of the global Activated Prothrombin Complex Concentrate (aPCC) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Activated Prothrombin Complex Concentrate (aPCC) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Activated Prothrombin Complex Concentrate (aPCC) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Activated Prothrombin Complex Concentrate (aPCC) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Activated Prothrombin Complex Concentrate (aPCC).
This report presents a comprehensive overview, market shares, and growth opportunities of Activated Prothrombin Complex Concentrate (aPCC) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 3F Prothrombin Complex Concentrate
- 4F Prothrombin Complex Concentrate
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda
- Octapharma AG
- CSL Behring GmbH
- Grifols
- What is the 10-year outlook for the global Activated Prothrombin Complex Concentrate (aPCC) market?
- What factors are driving Activated Prothrombin Complex Concentrate (aPCC) market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Activated Prothrombin Complex Concentrate (aPCC) market opportunities vary by end market size?
- How does Activated Prothrombin Complex Concentrate (aPCC) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Activated Prothrombin Complex Concentrate (aPCC) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Activated Prothrombin Complex Concentrate (aPCC) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Activated Prothrombin Complex Concentrate (aPCC) by Country/Region, 2021, 2025 & 2032
2.2 Activated Prothrombin Complex Concentrate (aPCC) Segment by Type
2.2.1 3F Prothrombin Complex Concentrate
2.2.2 4F Prothrombin Complex Concentrate
2.2.3 Activated Prothrombin Complex Concentrate (aPCC) Sales by Type
2.2.3.1 Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Activated Prothrombin Complex Concentrate (aPCC) Sale Price by Type (2021-2026)
2.3 Activated Prothrombin Complex Concentrate (aPCC) Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Activated Prothrombin Complex Concentrate (aPCC) Sales by Application
2.3.3.1 Global Activated Prothrombin Complex Concentrate (aPCC) Sale Market Share by Application (2021-2026)
2.3.3.2 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Activated Prothrombin Complex Concentrate (aPCC) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Activated Prothrombin Complex Concentrate (aPCC) Breakdown Data by Company
3.1.1 Global Activated Prothrombin Complex Concentrate (aPCC) Annual Sales by Company (2021-2026)
3.1.2 Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Company (2021-2026)
3.2 Global Activated Prothrombin Complex Concentrate (aPCC) Annual Revenue by Company (2021-2026)
3.2.1 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Company (2021-2026)
3.2.2 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Company (2021-2026)
3.3 Global Activated Prothrombin Complex Concentrate (aPCC) Sale Price by Company
3.4 Key Manufacturers Activated Prothrombin Complex Concentrate (aPCC) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Activated Prothrombin Complex Concentrate (aPCC) Product Location Distribution
3.4.2 Players Activated Prothrombin Complex Concentrate (aPCC) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE (APCC) BY GEOGRAPHIC REGION
4.1 World Historic Activated Prothrombin Complex Concentrate (aPCC) Market Size by Geographic Region (2021-2026)
4.1.1 Global Activated Prothrombin Complex Concentrate (aPCC) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Activated Prothrombin Complex Concentrate (aPCC) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Activated Prothrombin Complex Concentrate (aPCC) Market Size by Country/Region (2021-2026)
4.2.1 Global Activated Prothrombin Complex Concentrate (aPCC) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Activated Prothrombin Complex Concentrate (aPCC) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Activated Prothrombin Complex Concentrate (aPCC) Sales Growth
4.4 APAC Activated Prothrombin Complex Concentrate (aPCC) Sales Growth
4.5 Europe Activated Prothrombin Complex Concentrate (aPCC) Sales Growth
4.6 Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales Growth
5 AMERICAS
5.1 Americas Activated Prothrombin Complex Concentrate (aPCC) Sales by Country
5.1.1 Americas Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2021-2026)
5.1.2 Americas Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2021-2026)
5.2 Americas Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2021-2026)
5.3 Americas Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Activated Prothrombin Complex Concentrate (aPCC) Sales by Region
6.1.1 APAC Activated Prothrombin Complex Concentrate (aPCC) Sales by Region (2021-2026)
6.1.2 APAC Activated Prothrombin Complex Concentrate (aPCC) Revenue by Region (2021-2026)
6.2 APAC Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2021-2026)
6.3 APAC Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Activated Prothrombin Complex Concentrate (aPCC) by Country
7.1.1 Europe Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2021-2026)
7.1.2 Europe Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2021-2026)
7.2 Europe Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2021-2026)
7.3 Europe Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) by Country
8.1.1 Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2021-2026)
8.2 Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2021-2026)
8.3 Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Activated Prothrombin Complex Concentrate (aPCC)
10.3 Manufacturing Process Analysis of Activated Prothrombin Complex Concentrate (aPCC)
10.4 Industry Chain Structure of Activated Prothrombin Complex Concentrate (aPCC)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Activated Prothrombin Complex Concentrate (aPCC) Distributors
11.3 Activated Prothrombin Complex Concentrate (aPCC) Customer
12 WORLD FORECAST REVIEW FOR ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE (APCC) BY GEOGRAPHIC REGION
12.1 Global Activated Prothrombin Complex Concentrate (aPCC) Market Size Forecast by Region
12.1.1 Global Activated Prothrombin Complex Concentrate (aPCC) Forecast by Region (2027-2032)
12.1.2 Global Activated Prothrombin Complex Concentrate (aPCC) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Activated Prothrombin Complex Concentrate (aPCC) Forecast by Type (2027-2032)
12.7 Global Activated Prothrombin Complex Concentrate (aPCC) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Activated Prothrombin Complex Concentrate (aPCC) Product Portfolios and Specifications
13.1.3 Takeda Activated Prothrombin Complex Concentrate (aPCC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Octapharma AG
13.2.1 Octapharma AG Company Information
13.2.2 Octapharma AG Activated Prothrombin Complex Concentrate (aPCC) Product Portfolios and Specifications
13.2.3 Octapharma AG Activated Prothrombin Complex Concentrate (aPCC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Octapharma AG Main Business Overview
13.2.5 Octapharma AG Latest Developments
13.3 CSL Behring GmbH
13.3.1 CSL Behring GmbH Company Information
13.3.2 CSL Behring GmbH Activated Prothrombin Complex Concentrate (aPCC) Product Portfolios and Specifications
13.3.3 CSL Behring GmbH Activated Prothrombin Complex Concentrate (aPCC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CSL Behring GmbH Main Business Overview
13.3.5 CSL Behring GmbH Latest Developments
13.4 Grifols
13.4.1 Grifols Company Information
13.4.2 Grifols Activated Prothrombin Complex Concentrate (aPCC) Product Portfolios and Specifications
13.4.3 Grifols Activated Prothrombin Complex Concentrate (aPCC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Grifols Main Business Overview
13.4.5 Grifols Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Activated Prothrombin Complex Concentrate (aPCC) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Activated Prothrombin Complex Concentrate (aPCC) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Activated Prothrombin Complex Concentrate (aPCC) by Country/Region, 2021, 2025 & 2032
2.2 Activated Prothrombin Complex Concentrate (aPCC) Segment by Type
2.2.1 3F Prothrombin Complex Concentrate
2.2.2 4F Prothrombin Complex Concentrate
2.2.3 Activated Prothrombin Complex Concentrate (aPCC) Sales by Type
2.2.3.1 Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Activated Prothrombin Complex Concentrate (aPCC) Sale Price by Type (2021-2026)
2.3 Activated Prothrombin Complex Concentrate (aPCC) Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Activated Prothrombin Complex Concentrate (aPCC) Sales by Application
2.3.3.1 Global Activated Prothrombin Complex Concentrate (aPCC) Sale Market Share by Application (2021-2026)
2.3.3.2 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Activated Prothrombin Complex Concentrate (aPCC) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Activated Prothrombin Complex Concentrate (aPCC) Breakdown Data by Company
3.1.1 Global Activated Prothrombin Complex Concentrate (aPCC) Annual Sales by Company (2021-2026)
3.1.2 Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Company (2021-2026)
3.2 Global Activated Prothrombin Complex Concentrate (aPCC) Annual Revenue by Company (2021-2026)
3.2.1 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Company (2021-2026)
3.2.2 Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Company (2021-2026)
3.3 Global Activated Prothrombin Complex Concentrate (aPCC) Sale Price by Company
3.4 Key Manufacturers Activated Prothrombin Complex Concentrate (aPCC) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Activated Prothrombin Complex Concentrate (aPCC) Product Location Distribution
3.4.2 Players Activated Prothrombin Complex Concentrate (aPCC) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE (APCC) BY GEOGRAPHIC REGION
4.1 World Historic Activated Prothrombin Complex Concentrate (aPCC) Market Size by Geographic Region (2021-2026)
4.1.1 Global Activated Prothrombin Complex Concentrate (aPCC) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Activated Prothrombin Complex Concentrate (aPCC) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Activated Prothrombin Complex Concentrate (aPCC) Market Size by Country/Region (2021-2026)
4.2.1 Global Activated Prothrombin Complex Concentrate (aPCC) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Activated Prothrombin Complex Concentrate (aPCC) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Activated Prothrombin Complex Concentrate (aPCC) Sales Growth
4.4 APAC Activated Prothrombin Complex Concentrate (aPCC) Sales Growth
4.5 Europe Activated Prothrombin Complex Concentrate (aPCC) Sales Growth
4.6 Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales Growth
5 AMERICAS
5.1 Americas Activated Prothrombin Complex Concentrate (aPCC) Sales by Country
5.1.1 Americas Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2021-2026)
5.1.2 Americas Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2021-2026)
5.2 Americas Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2021-2026)
5.3 Americas Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Activated Prothrombin Complex Concentrate (aPCC) Sales by Region
6.1.1 APAC Activated Prothrombin Complex Concentrate (aPCC) Sales by Region (2021-2026)
6.1.2 APAC Activated Prothrombin Complex Concentrate (aPCC) Revenue by Region (2021-2026)
6.2 APAC Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2021-2026)
6.3 APAC Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Activated Prothrombin Complex Concentrate (aPCC) by Country
7.1.1 Europe Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2021-2026)
7.1.2 Europe Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2021-2026)
7.2 Europe Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2021-2026)
7.3 Europe Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) by Country
8.1.1 Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2021-2026)
8.2 Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2021-2026)
8.3 Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Activated Prothrombin Complex Concentrate (aPCC)
10.3 Manufacturing Process Analysis of Activated Prothrombin Complex Concentrate (aPCC)
10.4 Industry Chain Structure of Activated Prothrombin Complex Concentrate (aPCC)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Activated Prothrombin Complex Concentrate (aPCC) Distributors
11.3 Activated Prothrombin Complex Concentrate (aPCC) Customer
12 WORLD FORECAST REVIEW FOR ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE (APCC) BY GEOGRAPHIC REGION
12.1 Global Activated Prothrombin Complex Concentrate (aPCC) Market Size Forecast by Region
12.1.1 Global Activated Prothrombin Complex Concentrate (aPCC) Forecast by Region (2027-2032)
12.1.2 Global Activated Prothrombin Complex Concentrate (aPCC) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Activated Prothrombin Complex Concentrate (aPCC) Forecast by Type (2027-2032)
12.7 Global Activated Prothrombin Complex Concentrate (aPCC) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Activated Prothrombin Complex Concentrate (aPCC) Product Portfolios and Specifications
13.1.3 Takeda Activated Prothrombin Complex Concentrate (aPCC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Octapharma AG
13.2.1 Octapharma AG Company Information
13.2.2 Octapharma AG Activated Prothrombin Complex Concentrate (aPCC) Product Portfolios and Specifications
13.2.3 Octapharma AG Activated Prothrombin Complex Concentrate (aPCC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Octapharma AG Main Business Overview
13.2.5 Octapharma AG Latest Developments
13.3 CSL Behring GmbH
13.3.1 CSL Behring GmbH Company Information
13.3.2 CSL Behring GmbH Activated Prothrombin Complex Concentrate (aPCC) Product Portfolios and Specifications
13.3.3 CSL Behring GmbH Activated Prothrombin Complex Concentrate (aPCC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CSL Behring GmbH Main Business Overview
13.3.5 CSL Behring GmbH Latest Developments
13.4 Grifols
13.4.1 Grifols Company Information
13.4.2 Grifols Activated Prothrombin Complex Concentrate (aPCC) Product Portfolios and Specifications
13.4.3 Grifols Activated Prothrombin Complex Concentrate (aPCC) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Grifols Main Business Overview
13.4.5 Grifols Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Activated Prothrombin Complex Concentrate (aPCC) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Activated Prothrombin Complex Concentrate (aPCC) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 3F Prothrombin Complex Concentrate
Table 4. Major Players of 4F Prothrombin Complex Concentrate
Table 5. Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2021-2026) & (K Units)
Table 6. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Type (2021-2026)
Table 7. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Type (2021-2026)
Table 9. Global Activated Prothrombin Complex Concentrate (aPCC) Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Activated Prothrombin Complex Concentrate (aPCC) Sale by Application (2021-2026) & (K Units)
Table 11. Global Activated Prothrombin Complex Concentrate (aPCC) Sale Market Share by Application (2021-2026)
Table 12. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Application (2021-2026) & ($ million)
Table 13. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Application (2021-2026)
Table 14. Global Activated Prothrombin Complex Concentrate (aPCC) Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Company (2021-2026) & (K Units)
Table 16. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Company (2021-2026)
Table 17. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Company (2021-2026)
Table 19. Global Activated Prothrombin Complex Concentrate (aPCC) Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Activated Prothrombin Complex Concentrate (aPCC) Producing Area Distribution and Sales Area
Table 21. Players Activated Prothrombin Complex Concentrate (aPCC) Products Offered
Table 22. Activated Prothrombin Complex Concentrate (aPCC) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share Geographic Region (2021-2026)
Table 27. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Country/Region (2021-2026)
Table 31. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2021-2026) & (K Units)
Table 34. Americas Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Country (2021-2026)
Table 35. Americas Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2021-2026) & (K Units)
Table 37. Americas Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2021-2026) & (K Units)
Table 38. APAC Activated Prothrombin Complex Concentrate (aPCC) Sales by Region (2021-2026) & (K Units)
Table 39. APAC Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Region (2021-2026)
Table 40. APAC Activated Prothrombin Complex Concentrate (aPCC) Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2021-2026) & (K Units)
Table 42. APAC Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2021-2026) & (K Units)
Table 43. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2021-2026) & (K Units)
Table 44. Europe Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2021-2026) & (K Units)
Table 46. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Activated Prothrombin Complex Concentrate (aPCC)
Table 52. Key Market Challenges & Risks of Activated Prothrombin Complex Concentrate (aPCC)
Table 53. Key Industry Trends of Activated Prothrombin Complex Concentrate (aPCC)
Table 54. Activated Prothrombin Complex Concentrate (aPCC) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Activated Prothrombin Complex Concentrate (aPCC) Distributors List
Table 57. Activated Prothrombin Complex Concentrate (aPCC) Customer List
Table 58. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Activated Prothrombin Complex Concentrate (aPCC) Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Activated Prothrombin Complex Concentrate (aPCC) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Activated Prothrombin Complex Concentrate (aPCC) Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Activated Prothrombin Complex Concentrate (aPCC) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Activated Prothrombin Complex Concentrate (aPCC) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Takeda Basic Information, Activated Prothrombin Complex Concentrate (aPCC) Manufacturing Base, Sales Area and Its Competitors
Table 73. Takeda Activated Prothrombin Complex Concentrate (aPCC) Product Portfolios and Specifications
Table 74. Takeda Activated Prothrombin Complex Concentrate (aPCC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Takeda Main Business
Table 76. Takeda Latest Developments
Table 77. Octapharma AG Basic Information, Activated Prothrombin Complex Concentrate (aPCC) Manufacturing Base, Sales Area and Its Competitors
Table 78. Octapharma AG Activated Prothrombin Complex Concentrate (aPCC) Product Portfolios and Specifications
Table 79. Octapharma AG Activated Prothrombin Complex Concentrate (aPCC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Octapharma AG Main Business
Table 81. Octapharma AG Latest Developments
Table 82. CSL Behring GmbH Basic Information, Activated Prothrombin Complex Concentrate (aPCC) Manufacturing Base, Sales Area and Its Competitors
Table 83. CSL Behring GmbH Activated Prothrombin Complex Concentrate (aPCC) Product Portfolios and Specifications
Table 84. CSL Behring GmbH Activated Prothrombin Complex Concentrate (aPCC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. CSL Behring GmbH Main Business
Table 86. CSL Behring GmbH Latest Developments
Table 87. Grifols Basic Information, Activated Prothrombin Complex Concentrate (aPCC) Manufacturing Base, Sales Area and Its Competitors
Table 88. Grifols Activated Prothrombin Complex Concentrate (aPCC) Product Portfolios and Specifications
Table 89. Grifols Activated Prothrombin Complex Concentrate (aPCC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Grifols Main Business
Table 91. Grifols Latest Developments
Table 1. Activated Prothrombin Complex Concentrate (aPCC) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Activated Prothrombin Complex Concentrate (aPCC) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 3F Prothrombin Complex Concentrate
Table 4. Major Players of 4F Prothrombin Complex Concentrate
Table 5. Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2021-2026) & (K Units)
Table 6. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Type (2021-2026)
Table 7. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Type (2021-2026)
Table 9. Global Activated Prothrombin Complex Concentrate (aPCC) Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Activated Prothrombin Complex Concentrate (aPCC) Sale by Application (2021-2026) & (K Units)
Table 11. Global Activated Prothrombin Complex Concentrate (aPCC) Sale Market Share by Application (2021-2026)
Table 12. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Application (2021-2026) & ($ million)
Table 13. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Application (2021-2026)
Table 14. Global Activated Prothrombin Complex Concentrate (aPCC) Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Company (2021-2026) & (K Units)
Table 16. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Company (2021-2026)
Table 17. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Company (2021-2026)
Table 19. Global Activated Prothrombin Complex Concentrate (aPCC) Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Activated Prothrombin Complex Concentrate (aPCC) Producing Area Distribution and Sales Area
Table 21. Players Activated Prothrombin Complex Concentrate (aPCC) Products Offered
Table 22. Activated Prothrombin Complex Concentrate (aPCC) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share Geographic Region (2021-2026)
Table 27. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Activated Prothrombin Complex Concentrate (aPCC) Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Country/Region (2021-2026)
Table 31. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2021-2026) & (K Units)
Table 34. Americas Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Country (2021-2026)
Table 35. Americas Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2021-2026) & (K Units)
Table 37. Americas Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2021-2026) & (K Units)
Table 38. APAC Activated Prothrombin Complex Concentrate (aPCC) Sales by Region (2021-2026) & (K Units)
Table 39. APAC Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Region (2021-2026)
Table 40. APAC Activated Prothrombin Complex Concentrate (aPCC) Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2021-2026) & (K Units)
Table 42. APAC Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2021-2026) & (K Units)
Table 43. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2021-2026) & (K Units)
Table 44. Europe Activated Prothrombin Complex Concentrate (aPCC) Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2021-2026) & (K Units)
Table 46. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Activated Prothrombin Complex Concentrate (aPCC)
Table 52. Key Market Challenges & Risks of Activated Prothrombin Complex Concentrate (aPCC)
Table 53. Key Industry Trends of Activated Prothrombin Complex Concentrate (aPCC)
Table 54. Activated Prothrombin Complex Concentrate (aPCC) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Activated Prothrombin Complex Concentrate (aPCC) Distributors List
Table 57. Activated Prothrombin Complex Concentrate (aPCC) Customer List
Table 58. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Activated Prothrombin Complex Concentrate (aPCC) Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Activated Prothrombin Complex Concentrate (aPCC) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Activated Prothrombin Complex Concentrate (aPCC) Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Activated Prothrombin Complex Concentrate (aPCC) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Activated Prothrombin Complex Concentrate (aPCC) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Takeda Basic Information, Activated Prothrombin Complex Concentrate (aPCC) Manufacturing Base, Sales Area and Its Competitors
Table 73. Takeda Activated Prothrombin Complex Concentrate (aPCC) Product Portfolios and Specifications
Table 74. Takeda Activated Prothrombin Complex Concentrate (aPCC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Takeda Main Business
Table 76. Takeda Latest Developments
Table 77. Octapharma AG Basic Information, Activated Prothrombin Complex Concentrate (aPCC) Manufacturing Base, Sales Area and Its Competitors
Table 78. Octapharma AG Activated Prothrombin Complex Concentrate (aPCC) Product Portfolios and Specifications
Table 79. Octapharma AG Activated Prothrombin Complex Concentrate (aPCC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Octapharma AG Main Business
Table 81. Octapharma AG Latest Developments
Table 82. CSL Behring GmbH Basic Information, Activated Prothrombin Complex Concentrate (aPCC) Manufacturing Base, Sales Area and Its Competitors
Table 83. CSL Behring GmbH Activated Prothrombin Complex Concentrate (aPCC) Product Portfolios and Specifications
Table 84. CSL Behring GmbH Activated Prothrombin Complex Concentrate (aPCC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. CSL Behring GmbH Main Business
Table 86. CSL Behring GmbH Latest Developments
Table 87. Grifols Basic Information, Activated Prothrombin Complex Concentrate (aPCC) Manufacturing Base, Sales Area and Its Competitors
Table 88. Grifols Activated Prothrombin Complex Concentrate (aPCC) Product Portfolios and Specifications
Table 89. Grifols Activated Prothrombin Complex Concentrate (aPCC) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Grifols Main Business
Table 91. Grifols Latest Developments
LIST OF FIGURES
Figure 1. Picture of Activated Prothrombin Complex Concentrate (aPCC)
Figure 2. Activated Prothrombin Complex Concentrate (aPCC) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Activated Prothrombin Complex Concentrate (aPCC) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Country/Region (2025)
Figure 10. Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 3F Prothrombin Complex Concentrate
Figure 12. Product Picture of 4F Prothrombin Complex Concentrate
Figure 13. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Type in 2026
Figure 14. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Type (2021-2026)
Figure 15. Activated Prothrombin Complex Concentrate (aPCC) Consumed in Hospital
Figure 16. Global Activated Prothrombin Complex Concentrate (aPCC) Market: Hospital (2021-2026) & (K Units)
Figure 17. Activated Prothrombin Complex Concentrate (aPCC) Consumed in Clinic
Figure 18. Global Activated Prothrombin Complex Concentrate (aPCC) Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Activated Prothrombin Complex Concentrate (aPCC) Sale Market Share by Application (2025)
Figure 20. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Application in 2026
Figure 21. Activated Prothrombin Complex Concentrate (aPCC) Sales by Company in 2026 (K Units)
Figure 22. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Company in 2026
Figure 23. Activated Prothrombin Complex Concentrate (aPCC) Revenue by Company in 2026 ($ millions)
Figure 24. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Company in 2026
Figure 25. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Activated Prothrombin Complex Concentrate (aPCC) Sales 2021-2026 (K Units)
Figure 28. Americas Activated Prothrombin Complex Concentrate (aPCC) Revenue 2021-2026 ($ millions)
Figure 29. APAC Activated Prothrombin Complex Concentrate (aPCC) Sales 2021-2026 (K Units)
Figure 30. APAC Activated Prothrombin Complex Concentrate (aPCC) Revenue 2021-2026 ($ millions)
Figure 31. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales 2021-2026 (K Units)
Figure 32. Europe Activated Prothrombin Complex Concentrate (aPCC) Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Revenue 2021-2026 ($ millions)
Figure 35. Americas Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Country in 2026
Figure 36. Americas Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Country (2021-2026)
Figure 37. Americas Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Type (2021-2026)
Figure 38. Americas Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Application (2021-2026)
Figure 39. United States Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Region in 2026
Figure 44. APAC Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Region (2021-2026)
Figure 45. APAC Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Type (2021-2026)
Figure 46. APAC Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Application (2021-2026)
Figure 47. China Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 51. India Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Country in 2026
Figure 55. Europe Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Country (2021-2026)
Figure 56. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Type (2021-2026)
Figure 57. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Application (2021-2026)
Figure 58. Germany Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 59. France Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Application (2021-2026)
Figure 66. Egypt Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Activated Prothrombin Complex Concentrate (aPCC) in 2026
Figure 72. Manufacturing Process Analysis of Activated Prothrombin Complex Concentrate (aPCC)
Figure 73. Industry Chain Structure of Activated Prothrombin Complex Concentrate (aPCC)
Figure 74. Channels of Distribution
Figure 75. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Forecast by Region (2027-2032)
Figure 76. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Activated Prothrombin Complex Concentrate (aPCC)
Figure 2. Activated Prothrombin Complex Concentrate (aPCC) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Activated Prothrombin Complex Concentrate (aPCC) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Country/Region (2025)
Figure 10. Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 3F Prothrombin Complex Concentrate
Figure 12. Product Picture of 4F Prothrombin Complex Concentrate
Figure 13. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Type in 2026
Figure 14. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Type (2021-2026)
Figure 15. Activated Prothrombin Complex Concentrate (aPCC) Consumed in Hospital
Figure 16. Global Activated Prothrombin Complex Concentrate (aPCC) Market: Hospital (2021-2026) & (K Units)
Figure 17. Activated Prothrombin Complex Concentrate (aPCC) Consumed in Clinic
Figure 18. Global Activated Prothrombin Complex Concentrate (aPCC) Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Activated Prothrombin Complex Concentrate (aPCC) Sale Market Share by Application (2025)
Figure 20. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Application in 2026
Figure 21. Activated Prothrombin Complex Concentrate (aPCC) Sales by Company in 2026 (K Units)
Figure 22. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Company in 2026
Figure 23. Activated Prothrombin Complex Concentrate (aPCC) Revenue by Company in 2026 ($ millions)
Figure 24. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Company in 2026
Figure 25. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Activated Prothrombin Complex Concentrate (aPCC) Sales 2021-2026 (K Units)
Figure 28. Americas Activated Prothrombin Complex Concentrate (aPCC) Revenue 2021-2026 ($ millions)
Figure 29. APAC Activated Prothrombin Complex Concentrate (aPCC) Sales 2021-2026 (K Units)
Figure 30. APAC Activated Prothrombin Complex Concentrate (aPCC) Revenue 2021-2026 ($ millions)
Figure 31. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales 2021-2026 (K Units)
Figure 32. Europe Activated Prothrombin Complex Concentrate (aPCC) Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Revenue 2021-2026 ($ millions)
Figure 35. Americas Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Country in 2026
Figure 36. Americas Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Country (2021-2026)
Figure 37. Americas Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Type (2021-2026)
Figure 38. Americas Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Application (2021-2026)
Figure 39. United States Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Region in 2026
Figure 44. APAC Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Region (2021-2026)
Figure 45. APAC Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Type (2021-2026)
Figure 46. APAC Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Application (2021-2026)
Figure 47. China Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 51. India Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Country in 2026
Figure 55. Europe Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share by Country (2021-2026)
Figure 56. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Type (2021-2026)
Figure 57. Europe Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Application (2021-2026)
Figure 58. Germany Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 59. France Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share by Application (2021-2026)
Figure 66. Egypt Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Activated Prothrombin Complex Concentrate (aPCC) Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Activated Prothrombin Complex Concentrate (aPCC) in 2026
Figure 72. Manufacturing Process Analysis of Activated Prothrombin Complex Concentrate (aPCC)
Figure 73. Industry Chain Structure of Activated Prothrombin Complex Concentrate (aPCC)
Figure 74. Channels of Distribution
Figure 75. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Forecast by Region (2027-2032)
Figure 76. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Activated Prothrombin Complex Concentrate (aPCC) Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Activated Prothrombin Complex Concentrate (aPCC) Revenue Market Share Forecast by Application (2027-2032)
